Takip et
Nilanjana Banerjee
Nilanjana Banerjee
Diğer adlarN Banerjee, Nila Banerjee
Regeneron Genetics Center, Philips Research, Columbia University, Cold Spring Harbor Lab
regeneron.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Exome sequencing and analysis of 454,787 UK Biobank participants
JD Backman, AH Li, A Marcketta, D Sun, J Mbatchou, MD Kessler, ...
Nature 599 (7886), 628-634, 2021
6822021
Exome sequencing and characterization of 49,960 individuals in the UK Biobank
CV Van Hout, I Tachmazidou, JD Backman, JD Hoffman, D Liu, ...
Nature 586 (7831), 749-756, 2020
4702020
Identifying combinatorial regulation of transcription factors and binding motifs
M Kato, N Hata, N Banerjee, B Futcher, MQ Zhang
Genome biology 5, 1-13, 2004
2192004
Identifying cooperativity among transcription factors controlling the cell cycle in yeast
N Banerjee, MQ Zhang
Nucleic acids research 31 (23), 7024-7031, 2003
2032003
A novel saliva-based microRNA biomarker panel to detect head and neck cancers
C Salazar, R Nagadia, P Pandit, J Cooper-White, N Banerjee, N Dimitrova, ...
Cellular oncology 37, 331-338, 2014
1862014
Common and rare variant associations with clonal haematopoiesis phenotypes
MD Kessler, A Damask, S O’Keeffe, N Banerjee, D Li, K Watanabe, ...
Nature 612 (7939), 301-309, 2022
1612022
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
S Kamalakaran, V Varadan, HEG Russnes, D Levy, J Kendall, A Janevski, ...
Molecular oncology 5 (1), 77-92, 2011
1592011
Interacting models of cooperative gene regulation
D Das, N Banerjee, MQ Zhang
Proceedings of the National Academy of Sciences 101 (46), 16234-16239, 2004
1592004
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease
JE Horowitz, JA Kosmicki, A Damask, D Sharma, GHL Roberts, AE Justice, ...
Nature genetics 54 (4), 382-392, 2022
1492022
Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank
CV Van Hout, I Tachmazidou, JD Backman, JX Hoffman, B Ye, AK Pandey, ...
BioRxiv, 572347, 2019
1102019
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals
JA Kosmicki, JE Horowitz, N Banerjee, R Lanche, A Marcketta, E Maxwell, ...
The American Journal of Human Genetics 108 (7), 1350-1355, 2021
892021
Translating next generation sequencing to practice: opportunities and necessary steps
S Kamalakaran, V Varadan, A Janevski, N Banerjee, D Tuck, ...
Molecular Oncology 7 (4), 743-755, 2013
552013
Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
E Lum, M Vigliotti, N Banerjee, N Cutter, KO Wrzeszczynski, S Khan, ...
Gynecologic oncology 130 (2), 369-376, 2013
482013
Genome-wide discovery of modulators of transcriptional interactions in human B lymphocytes
K Wang, I Nemenman, N Banerjee, AA Margolin, A Califano
Research in Computational Molecular Biology: 10th Annual International …, 2006
402006
InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer
N Dimitrova, AB Nagaraj, A Razi, S Singh, S Kamalakaran, N Banerjee, ...
Oncogene 36 (17), 2472-2482, 2017
272017
Effective normalization for copy number variation detection from whole genome sequencing
A Janevski, V Varadan, S Kamalakaran, N Banerjee, N Dimitrova
BMC genomics 13, 1-11, 2012
262012
Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe …
JE Horowitz, JA Kosmicki, A Damask, D Sharma, GHL Roberts, AE Justice, ...
MedRxiv, 2021
232021
Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease
JE Horowitz, JA Kosmicki, A Damask, D Sharma, GHL Roberts, AE Justice, ...
MedRxiv, 2020
222020
Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers
V Varadan, S Kamalakaran, H Gilmore, N Banerjee, A Janevski, ...
International journal of cancer 138 (3), 747-757, 2016
222016
System and method for real time clinical questions presentation and management
A Janevski, S Kamalakaran, N Banerjee, V Varadan, N Dimitrova, ...
US Patent 11,309,060, 2022
202022
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20